Table 2.

Concentrations of plasma lysophospholipids in the subgroups of chronic kidney disease patients and the control group

Parameter		Subgroup
		CT	HD		PD	RT		Con	P*
			D1	D2		D1	D2
LPA [μM]	Mean ± SD	1.61 ± 1.35	0.99 ± 0.78	1.41 ± 1.75	2.43 ± 1.99	1.31 ± 1.02	2.12 ± 1.33	0.96 ± 0.58	< 0.001
	Median	1.28	0.94	0.80	1.96	0.89	1.74	0.82
LPC [μM]	Mean ± SD	6.29 ±3.24	5.69 ±3,34	6.74 ±3.89	7.52 ±3.37	7.01 ±3.87	7.00 ±3.48	9.06 ±4.02	< 0.001
	Median	5.61	5.12	5.82	6.46	5.98	6.65	8.51

*p value for differences between CT, HD D1, HD D2, PD, RT D1, RT D2 and Con in Kruskal-Wallis test;

LPA – lysophosphatidic acid, LPC – lysophosphatidylcholine, CT –patients treated conservatively, HD D1–patients on hemodialysis before the dialysis (1st donation), HD D1–patients on hemodialysis after the dialysis (2nd donation), PD –patients on peritoneal dialysis, RT D1– renal transplant recipients before the transplantation (1st donation), RT D2– renal transplant recipients after the transplantation (2nd donation), Con – control group, W – women, M – men, SD – standard deviation